Pharma fonden ApS
CVR 45423859 · Private limited company (ApS) · Active · Low risk
Pharma fonden ApS is a Private limited company (ApS), founded on , based in København Ø. The company is registered in the industry ikke-finansielle holdingselskaber. Our model estimates a bankruptcy risk of 0.5% over the next 12 months, which is 0.4 times the average for Danish companies. 1 annual report has been published. The latest annual report (31 Dec 2025) shows equity of DKK 786k and a net result of DKK -2,129. CEO: Kristian Worziger Nielsen.
Bankruptcy risk for Pharma fonden ApS
0.4 × the average (1.41%) · higher risk than 60% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 45423859
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (1 years)
- Address
- Landskronagade 7, 1. tv
2100 København Ø - Municipality
- København
- Industry
- Ikke-finansielle holdingselskaber (642120)
Bankruptcies in the industry: Ikke-finansielle holdingselskaber - Share capital
- DKK 40k
- Audit opted out
- Yes
Warning signs
| Annual reports filed late | 0 of 1 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 100.0% |
| Current ratio | – |
| Moves (last 2 years) | 0 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 2 |
| Other companies at the address | 4 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 |
|---|---|
| Gross profit | DKK -2,129 |
| Net profit | DKK -2,129 |
| Equity | DKK 786k |
| Total assets | DKK 786k |
| Cash | DKK 5,871 |
| Short-term debt | DKK 0 |
| Tax owed | DKK 0 |
| Avg. employees | 0 |
Latest annual report: Reporting class B · auditor's statement: No assurance.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 25 Feb 2025 – 31 Dec 2025 | 116 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Kristian Worziger Nielsen | Current | |
| Owner (67%) | Kristian Worziger Nielsen | Current | |
| Owner (10%) | Sara Marie Arambula | Current | |
| Founder | Kristian Worziger Nielsen | Current |
The CEOs' other companies
Kristian Worziger Nielsen – 4 other companies, of which 2 bankrupt
- Culture ThinkTank IVS Bankrupt 2 Mar 2021
- Working Konsultants IVS Bankrupt 23 Feb 2021
- ConScience ApS Active
- CultureThink Holding ApS Active
Address history (0 moves)
| Landskronagade 7, 1. tv, 2100 København Ø |
Other companies at the same address
- Culture ThinkTank IVS Bankrupt
- Working Konsultants IVS Bankrupt
- CultureThink Holding ApS Active
- This is so Estella ApS Active
Similar companies in København
- ANTECH INVEST A/S København K
- NIELS BUCHHOLST A/S København Ø
- METROPOLITAN HOLDING ApS København S
- JOOST HOLDING ApS København K
- TENNECO HOLDINGS DANMARK ApS København V
- GENUA A/S København K
- AHM AF 1997 HOLDING ApS Nordhavn
- T. K. BOESEN HOLDING ApS København K
- Hallerup Group ApS København K
- B. EYDE-JØRGENSEN ApS København V
- BRØDR. JØRGENSEN HOLDING A/S København K
- GULDBERG EJENDOMS- OG INVESTERINGSSELSKAB A/S København N
Questions and answers about Pharma fonden ApS
Has Pharma fonden ApS gone bankrupt?
No, Pharma fonden ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Pharma fonden ApS?
Our model estimates a bankruptcy risk of 0.5% over the next 12 months (low risk), which is 0.4 times the average for Danish companies.
Who is the CEO of Pharma fonden ApS?
Kristian Worziger Nielsen is the CEO of Pharma fonden ApS.
When was Pharma fonden ApS founded?
Pharma fonden ApS was founded on 25 February 2025.
What is the equity of Pharma fonden ApS?
Equity was DKK 786k according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.